LUND, S.E., April 7, 2025 – TFS HealthScience, a leading global contract research organization (CRO), is proud to announce its participation in a dynamic lineup of industry-leading conferences and events taking place between April and June 2025. These events, spanning North America, Europe, and the Middle East, offer valuable opportunities to exchange knowledge, foster strategic partnerships, and contribute to the advancement of innovation in clinical research. TFS’s presence across these global forums reflects its ongoing commitment to therapeutic excellence, sponsor collaboration, and patient-centered research in key focus areas including dermatology, neuroscience, oncology, and ophthalmology.
Building on this commitment, TFS’s upcoming engagements underscore the organization’s deep therapeutic expertise and collaborative approach to advancing clinical development. In the neuroscience space, TFS will attend both AD/PD™ (Vienna, April 1–5) and the European Psychiatric Association (EPA) Congress (Madrid, April 5–8), reaffirming its long-standing role in supporting complex central nervous system (CNS) trials. These gatherings convene global leaders in neurodegenerative and psychiatric research—critical areas where TFS continues to provide tailored, operationally robust solutions for sponsors navigating challenging therapeutic landscapes.
In oncology, a cornerstone of global clinical development, TFS will attend ASCO (Chicago, May 30–June 3), the world’s largest cancer research meeting, exhibiting at Booth #37130. The team will also join CTO West Coast (Burlingame, May 14–15), engaging with innovators and early-phase developers driving the next wave of precision oncology. These events support TFS’s strategic focus on helping oncology sponsors navigate fast-moving pipelines and increasingly sophisticated trial designs.
TFS will also participate in ARVO (Salt Lake City, May 4–8), one of the field’s most significant ophthalmology research gatherings. With extensive experience in both front- and back-of-eye indications, TFS continues to invest in the specialized expertise required to support trials in this highly nuanced space.
Beyond these therapeutic areas, TFS will take part in a range of global events focused on innovation, biotech partnerships, and clinical outsourcing. These include the World Orphan Drug Congress (Boston, April 22–24), Swiss Biotech Day (Basel, May 5–6), Bionnale (Berlin, May 14–15), and the International Congress of Dermatology (Rome, June 18–21). The team will also take part in multiple OCT (Outsourcing in Clinical Trials) conferences across Southeast US, Europe, East Coast US, and the United Kingdom; as well as the COG (Clinical Outsourcing Group) series in the Nordics and New England, Biomed Israel, and the Future of Danish & Swedish Life Science event in Lund, Sweden.
Each of these engagements offers TFS an opportunity to exchange insights with peers, stay attuned to emerging trends, and contribute to conversations shaping the future of clinical research. These events are not only about visibility, but also about listening, learning, and collaborating—ensuring TFS teams remain at the cutting edge of therapeutic and operational innovation.
TFS’s Q2 calendar highlights not just its global presence, but its purpose: advancing research that matters, scaling solutions that serve sponsors effectively, and accelerating access to transformative treatments for patients worldwide.
For the full list of events and to connect with the TFS team, visit https://tfscro.com/events.
About TFS HealthScience
TFS HealthScience is a full-service, global Contract Research Organization (CRO) that partners with biotechnology and pharmaceutical companies to advance innovative treatments and improve patient outcomes. With operations across 40 countries, TFS and its strategic partners provide tailored strategic resourcing solutions and clinical development services in specialized therapeutic areas, including dermatology, internal medicine, neuroscience, oncology, and ophthalmology. Dedicated to empowering partners and enriching lives, TFS offers flexible solutions that combine global reach with the agility and responsiveness of a mid-sized CRO.
For more information, visit www.tfscro.com.